Trump drug tariffs inch closer as Commerce Department launches 232 investigationnews2025-04-14T22:27:27+00:00April 14th, 2025|Endpoints News|
Bristol Myers says Camzyos fails Phase 3 study in genetic heart conditionnews2025-04-14T21:40:57+00:00April 14th, 2025|Endpoints News|
CDC vaccine advisors set to meet this week after two-month delaynews2025-04-14T19:39:55+00:00April 14th, 2025|Endpoints News|
AbbVie and Sandoz resolve court spat over Rinvoq patentsnews2025-04-14T19:22:34+00:00April 14th, 2025|Endpoints News|
Sandoz sues Amgen over nearly decadelong launch delay for Enbrel biosimilarnews2025-04-14T17:32:12+00:00April 14th, 2025|Endpoints News|
Pfizer’s next move after ending work on oral obesity drug danuglipronnews2025-04-14T17:14:54+00:00April 14th, 2025|Endpoints News|
Primate researchers gird for funding cuts as NIH fights court blocknews2025-04-14T15:00:31+00:00April 14th, 2025|Endpoints News|
Ironwood to look for alternative paths after FDA asks for another Phase 3news2025-04-14T12:40:17+00:00April 14th, 2025|Endpoints News|
Pharma tariffs to arrive ‘in the next month or two,’ commerce secretary saysnews2025-04-14T11:00:54+00:00April 14th, 2025|Endpoints News|
Novartis follows Lilly and J&J in announcing multibillion-dollar US manufacturing investmentnews2025-04-10T19:40:42+00:00April 10th, 2025|Endpoints News|
